PCN350 Treatment Sequences of Patients Surviving at Least Two Years after Initiation of Nivolumab in Previously Treated Advanced Non-Small Cell Lung Cancer (aNSCLC): Contribution of Time-Sequence K-Clustering Analysis

Autor:	C.Y. Calvet, F. Dayde, François-Emery Cotté, A. Batisse, B. Jouaneton, Anne-Françoise Gaudin, Christos Chouaid, R. Corre, M. Giaj-Levra, V. Grumberg, Jean-Baptiste Assié
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Time sequence medicine.disease Internal medicine Medicine Non small cell Nivolumab business Lung cancer Previously treated
Zdroj:	Value in Health. 23:S485
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9c15003ab40f0f3e1d757f1ffb22445b https://doi.org/10.1016/j.jval.2020.08.487 Zobrazit plný text záznamu Full Text from ScienceDirect